These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23744802)

  • 1. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion.
    Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H
    Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
    Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H
    Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of stem cell response and bone growth on biomaterials by fully non-peptidic integrin selective ligands.
    Fraioli R; Neubauer S; Rechenmacher F; Bosch BM; Dashnyam K; Kim JH; Perez RA; Kim HW; Gil FJ; Ginebra MP; Manero JM; Kessler H; Mas-Moruno C
    Biomater Sci; 2019 Mar; 7(4):1281-1285. PubMed ID: 30735211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
    Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
    Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicking bone extracellular matrix: integrin-binding peptidomimetics enhance osteoblast-like cells adhesion, proliferation, and differentiation on titanium.
    Fraioli R; Rechenmacher F; Neubauer S; Manero JM; Gil J; Kessler H; Mas-Moruno C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():191-200. PubMed ID: 25637448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity.
    Neubauer S; Rechenmacher F; Brimioulle R; Di Leva FS; Bochen A; Sobahi TR; Schottelius M; Novellino E; Mas-Moruno C; Marinelli L; Kessler H
    J Med Chem; 2014 Apr; 57(8):3410-7. PubMed ID: 24654918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
    Sani S; Messe M; Fuchs Q; Pierrevelcin M; Laquerriere P; Entz-Werle N; Reita D; Etienne-Selloum N; Bruban V; Choulier L; Martin S; Dontenwill M
    Chembiochem; 2021 Apr; 22(7):1151-1160. PubMed ID: 33140906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective binding and lateral clustering of α5β1 and αvβ3 integrins: Unraveling the spatial requirements for cell spreading and focal adhesion assembly.
    Schaufler V; Czichos-Medda H; Hirschfeld-Warnecken V; Neubauer S; Rechenmacher F; Medda R; Kessler H; Geiger B; Spatz JP; Cavalcanti-Adam EA
    Cell Adh Migr; 2016 Sep; 10(5):505-515. PubMed ID: 27003228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side chain effect in the modulation of α
    Ferrazzano L; Corbisiero D; Potenza E; Baiula M; Dattoli SD; Spampinato S; Belvisi L; Civera M; Tolomelli A
    Sci Rep; 2020 May; 10(1):7410. PubMed ID: 32366988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface Co-presentation of BMP-2 and integrin selective ligands at the nanoscale favors α
    Posa F; Baha-Schwab EH; Wei Q; Di Benedetto A; Neubauer S; Reichart F; Kessler H; Spatz JP; Albiges-Rizo C; Mori G; Cavalcanti-Adam EA
    Biomaterials; 2021 Jan; 267():120484. PubMed ID: 33142116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel micropillars with integrin selective peptidomimetic functionalized nanopatterned tops: a new tool for the measurement of cell traction forces transmitted through αvβ3- or α5β1-integrins.
    Rahmouni S; Lindner A; Rechenmacher F; Neubauer S; Sobahi TR; Kessler H; Cavalcanti-Adam EA; Spatz JP
    Adv Mater; 2013 Nov; 25(41):5869-74. PubMed ID: 23913640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of α
    Diaz C; Neubauer S; Rechenmacher F; Kessler H; Missirlis D
    J Cell Sci; 2020 Jan; 133(1):. PubMed ID: 31780581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biokinetic and metabolic characterization of the ⁶⁸Ga-labelled α5β1-selective peptidomimetic FR366.
    D'Alessandria C; Pohle K; Rechenmacher F; Neubauer S; Notni J; Wester HJ; Schwaiger M; Kessler H; Beer AJ
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):953-963. PubMed ID: 26497698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: a method to discriminate integrin subtypes in vitro.
    Rechenmacher F; Neubauer S; Polleux J; Mas-Moruno C; De Simone M; Cavalcanti-Adam EA; Spatz JP; Fässler R; Kessler H
    Angew Chem Int Ed Engl; 2013 Jan; 52(5):1572-5. PubMed ID: 23345131
    [No Abstract]   [Full Text] [Related]  

  • 17. αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?
    Rocha LA; Learmonth DA; Sousa RA; Salgado AJ
    Biotechnol Adv; 2018; 36(1):208-227. PubMed ID: 29155160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
    Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
    Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands.
    Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M
    ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.